To The Moon

As of the close on Friday, $S&P/ASX 200(XJO.AU)$ closed at 7,575.90 on Friday, down 0.87% in the past 5 days. 

1. $Resmed DRC(RMD.AU)$ +14.01%

• The ResMed Inc share price is avoiding the market selloff and racing higher on Friday. In early trade, the sleep disorder treatment company's shares are up an impressive 10% to $31.50.

• TLX stock rose 14.01% this week primarily due to Investors have been fighting to get hold of the company's shares following the release of its third quarter update.

• Another big positive was the company's gross margin, which improved 260 basis points to 57.9% on a GAAP basis and 240 basis points to 58.5% on a non-GAAP basis. This was ahead of the consensus estimate for a gross margin of 57.6%.

2. $Newmont Corp(NEM.AU)$ +9.92%

• The Newmont Corporation share price is catching the eye on Friday and is on course to end the week in style.

• Newmont share price rocketing because of the release, Investors have been buying the gold miner's shares this morning after its released a fourth quarter update that was ahead of expectations.

• he Newcrest owner's adjusted net income was US$630 million or US$0.55 per diluted share. This is up 39.4% and 19.5%, respectively, on the prior quarter. The latter was significantly better than the market was expecting, with the consensus estimate at US$0.36 per share. This goes some way to explaining why the Newmont share price is taking off.

3. $TELIX PHARMACEUTICALS LTD(TLX.AU)$ +8.67%

• Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals.

• According to the release, during the first quarter of FY 2024, Telix reported unaudited total revenue of US$114.9 million (A$175 million). This represents a sizeable 18% increase on the US$97.1 million (A$148.1 million) that was recorded during the fourth quarter of FY 2023.

• The Telix share price is up 62% over the last 12 months.

4. $IRESS LTD(IRE.AU)$ +7.71%

• IRESS Limited engages in the designing and developing software and services for the financial services industry in the Asia Pacific, the United Kingdom and Europe, Africa, and North America.

• Over the next couple years, the company is expected to grow its cash from operations at a double-digit rate of 31%, ramping up from its current levels of AU$92m to AU$120m in three years’ time. Furthermore, breaking down growth into a year on year basis, IRE is able to increase its growth rate each year, from 9.0% in the upcoming year, to 9.5% by the end of the third year. The overall future outlook seems buoyant if IRE can maintain its levels of capital expenditure as well.

5. $CHAMPION IRON LTD(CIA.AU)$ +5.64%

• With earnings growth that's superior to most other companies of late, Champion Iron has been doing relatively well. It might be that many expect the strong earnings performance to degrade substantially, which has repressed the P/E. If not, then existing shareholders have reason to be quite optimistic about the future direction of the share price.

• Champion Iron Limited's price-to-earnings (or "P/E") ratio of 10.5x might make it look like a buy right now compared to the market in Australia